Search results
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 13 hours agoMerck has announced that its Phase III KEYNOTE-B21 (ENGOT-en11/GOG-3053) clinical trial of KEYTRUDA...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 1 day agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 6 hours agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Merck Study of Keytruda With Chemotherapy in Endometrial Cancer Fails to Meet Endpoint
Market Watch· 1 day agoMerck was hit with a setback in its efforts to expand its blockbuster cancer immunotherapy Keytruda after a late-stage study of its use in combination with chemotherapy to ...
Dow Jones Today: Stocks Mixed As Dow on Track To Extend Winning Streak to Eight Consecutive Sessions
Investopedia· 4 hours agoModerna (MRNA) slid 4% as the biotech’s effort to move beyond just a COVID-19 vaccine was stalled...
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 hours agoBioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2024 Earnings Call Transcript May 9, 2024 BioXcel...
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 7 hours agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in...
FOX 4 Kansas City· 10 hours agoThe translational study provides pre-clinical evidence to support Aethlon's planned phase 1 safety,...
Aethlon Medical Shares Double After Positive Results from Early Trial of Hemopurifier
Market Watch· 10 hours agoThe therapeutic company said the translational study provides pre-clinical evidence to support its planned phase 1 safety, feasibility and dose-finding clinical trials of the Hemopurifier in ...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 1 day agoThe oncology market is known for its strong pricing power, with cancer drugs typically carrying high price tags and significant margins. While Pfizer's...
